Zsolt Ablonczy Selected Research

Lipofuscin

12/2017	Bis(monoacylglycero)phosphate lipids in the retinal pigment epithelium implicate lysosomal/endosomal dysfunction in a model of Stargardt disease and human retinas.
11/2015	Determination of N-retinylidene-N-retinylethanolamine (A2E) levels in central and peripheral areas of human retinal pigment epithelium.
10/2015	A2E and lipofuscin distributions in macaque retinal pigment epithelium are similar to human.
1/2015	The 11-cis Retinal Origins of Lipofuscin in the Retina.
1/2015	A2E and Lipofuscin.
4/2014	The utilization of fluorescence to identify the components of lipofuscin by imaging mass spectrometry.
11/2013	Similar molecules spatially correlate with lipofuscin and N-retinylidene-N-retinylethanolamine in the mouse but not in the human retinal pigment epithelium.
6/2012	Lipofuscin and N-retinylidene-N-retinylethanolamine (A2E) accumulate in retinal pigment epithelium in absence of light exposure: their origin is 11-cis-retinal.
6/2011	Spatial localization of A2E in the retinal pigment epithelium.
11/2010	Mass spectrometry provides accurate and sensitive quantitation of A2E.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zsolt Ablonczy Research Topics

Disease

14	Macular Degeneration (Age-Related Maculopathy) 04/2016 - 06/2009
6	Retinal Degeneration 12/2017 - 01/2010
5	Stargardt Disease 12/2017 - 11/2010
3	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 10/2009
2	Hyperglycemia 01/2016 - 01/2016
2	Choroidal Neovascularization 05/2014 - 12/2009
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2013 - 12/2009
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 12/2017
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2017
1	Glaucoma 04/2016
1	Cataract (Cataracts) 04/2016
1	Blister (Bulla) 04/2014
1	Papilledema 04/2014
1	Neuroblastoma 01/2014
1	Retinal Diseases 06/2012
1	Cardiomegaly (Heart Hypertrophy) 07/2010
1	Hypertrophy 07/2010

Drug/Important Bio-Agent (IBA)

10	LipofuscinIBA 12/2017 - 11/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 12/2009
2	RetinoidsIBA 12/2017 - 11/2010
2	LipidsIBA 12/2017 - 04/2016
2	Retinaldehyde (Retinal)IBA 01/2015 - 01/2015
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2014 - 10/2009
2	Amyloid beta-PeptidesIBA 01/2010 - 10/2009
1	A2-E (N-retinylidene-N-retinylethanolamine)IBA 12/2017
1	CholesterolIBA 12/2017
1	bis(monoacylglyceryl)phosphateIBA 12/2017
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	theasinensin AIBA 01/2016
1	TubulinIBA 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	CytokinesIBA 04/2014
1	Dihydrotachysterol (AT 10)IBA 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014
1	ZM323881IBA 04/2014
1	AlbuminsIBA 04/2014
1	EstersIBA 01/2014
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2014
1	Advanced Glycation End ProductsIBA 01/2013
1	A-factor (Streptomyces)IBA 11/2012
1	Pharmaceutical PreparationsIBA 06/2011
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 07/2010
1	Atrial Natriuretic Factor (ANF)IBA 12/2009
1	Peptides (Polypeptides)IBA 10/2009
1	Amyloid (Amyloid Fibrils)IBA 10/2009
1	Proteins (Proteins, Gene)FDA Link 10/2009
1	Complement System Proteins (Complement)IBA 06/2009

Therapy/Procedure

1	Therapeutics 01/2015
1	Lasers (Laser) 12/2009